Sun Pharma Q2 profit dips 11% to Rs 453.8 cr

News Flash

SUBMITTED TO LYONDELLBASELL NON BIDDING OFFER TO ACQUIRE FOR CASH
CASH OFFER FOR A CONTROLLING STAKE UPON EMERGENCE FROM CHAPTER 11
OFFER PURSUANT TO ITS PLAN OF REORGANISATION
OFFER IS PRELIMINARY AND SUBJECT TO CUSTOMARY CONDITIONS
RIL REVIEWING OTHER GROWTH OPPORTUNITIES FOR GROWTH
Stock updates: SMS STO followed by scrip name to 56388
Finance buzz: Logon to mobile.ndtv.com on GPRS browsers
SMS INDEX to 56388 for live market updates
Stock moves on WAP: Logon to mobile.ndtv.com on GPRS browser
For Kingfisher Airlines flight updates sms KING to 56388
Email us at buyorsell@ndtv.com
Call us at 011-26201171
DELL LOST 10% ON FRIDAY AFTER MISSING REVENUES & EARNINGS TARGET FOR Q3
GOLDMAN SACHS DOWN 1.6%, GE DOWN 1.1%, CISCO DOWN 1%, MERCK UP 3.2%
DELL LOST 10% ON FRIDAY AFTER MISSING REVENUES & EARNINGS TARGET FOR Q2
DOW JONES FALLS FOR 3RD STRAIGHT DAY TO END LOWER BY 0.1% ON FRIDAY
NASDAQ DOWN 0.5%, S&P 500 INDEX LOWER BY 0.3% AT CLOSE ON FRIDAY
U.S MARKETS ENDED LOWER ON FRIDAY AS TECH STOCKS TOOK THE BIGGEST HIT
RELIANCE IND PLACES RS.115 CR ORDER WITH NORWAY'S AKER SOLUTIONS
AKER BAGGED SUB SEA PRODUCTION ORDER FROM RIL IN 2006 ALSO
AKER SOLUTIONS TO PROVIDE SUPPORT SERVICES IN KG BASIN
AKER IS A NORWEGIAN SERVICE PROVIDER CO FOR OIL AND GAS OPERATIONS
TO EXPAND PANTNAGAR CAPACITY TO 70,000 UNITS IN NEXT FEW MONTHS
TO ENTER INTO CUSTOMIZED MOTOR CYCLE BIZ VIA PRO-BIKING SHOWROOMS
DII'S NET BUY RS.18.46 CR IN EQUITIES ON NOVEMBER 20 (PROV)
MUTUAL FUNDS NET SELL RS.176.7 CR IN EQUITIES ON NOVEMBER 19
FOREIGN FUNDS NET SELL RS.463.89 CR IN EQUITIES ON NOVEMBER 20 (PROV)
PORTING CHARGES TO BECOME APPLICABLE FROM DECEMBER 31, 2009
MNP ALLOWS USERS TO CHANGE OPERATORS WHILE RETAINING MOBILE NOS
USERS TO PAY MAX OF RS.19 TO CHANGE OPERATOR WHILE RETAINING OLD NUMBER

Updated: 28/10/2009 | 05:24 PM IST

Top Stories

Press Trust of India

Wednesday, October 28, 2009 (Mumbai)

Blog

Comments:

Read (0)

Post

Rate the story

The country's most valued drug maker Sun Pharmaceutical Industries on Wednesday reported a decline of 11 per cent in its consolidated net profit to Rs 453.81 crore for the second quarter of the current fiscal.

The company had a consolidated net profit of Rs 512.77 crore during the same quarter last year.

However, consolidated total income of the pharma major rose to Rs 1,185.17 crore in the latest quarter from Rs 1,177.64 crore in the year-ago period, Sun Pharma said in a statement to the Bombay Stock Exchange.

On standalone basis, Sun Pharma posted a net profit of Rs 203.06 crore for the quarter under review, 33 per cent down from Rs 303.14 crore for the same period last fiscal.

Shares of Sun Pharma were trading at Rs 1,364.95, down 0.06 per cent in the afternoon trade on the BSE.